Clinical Trial Update: Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.) [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting safety and efficacy results for SR-hGH Declage Inj. in growth hormone deficiency; the study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Declage Inj. (somatropin)

Snippet

Sponsor: LG Life Sciences | Conditions: Growth Hormone Deficiency | Phase 4 | Status: COMPLETED